Does TECLISTAMAB Cause Hepatitis fulminant? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hepatitis fulminant have been filed in association with TECLISTAMAB (TECVAYLI). This represents 1.4% of all adverse event reports for TECLISTAMAB.
17
Reports of Hepatitis fulminant with TECLISTAMAB
1.4%
of all TECLISTAMAB reports
17
Deaths
1
Hospitalizations
How Dangerous Is Hepatitis fulminant From TECLISTAMAB?
Of the 17 reports, 17 (100.0%) resulted in death, 1 (5.9%) required hospitalization.
Is Hepatitis fulminant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Hepatitis fulminant?
ACETAMINOPHEN (394)
NIVOLUMAB (60)
DEXAMETHASONE (59)
RITUXIMAB (51)
PEMBROLIZUMAB (50)
ATORVASTATIN (45)
IBUPROFEN (45)
PREDNISOLONE (45)
TRAMADOL (42)
AMIODARONE (40)
Which TECLISTAMAB Alternatives Have Lower Hepatitis fulminant Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR